NCT01603095
Achondroplasia
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
Multicenter, multinational study to collect consistent baseline growth measurements on pediatric patients with Achondroplasia being considered for subsequent enrollment in future studies sponsored by BioMarin. No study drug is administered.
All
Up to 17 Years
No
Observational
363
2012-04
2021-04-13
Los Angeles, California, United States
Oakland, California, United States
Wilmington, Delaware, United States
Decatur, Georgia, United States
Chicago, Illinois, United States
Cincinnati, Ohio, United States
Nashville, Tennessee, United States
Houston, Texas, United States
Milwaukee, Wisconsin, United States
Parkville, Victoria, Australia
Westmead, , Australia
Osaka, , Japan
Saitama, , Japan
Tokushima, , Japan
Barcelona, , Spain
Barcelona, , Spain
Málaga, , Spain
Istanbul, , Turkey
London, , United Kingdom
Sheffield, , United Kingdom
By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.
*required fields
"*" indicates required fields